Sunil Kumar Singh

Employment

• University of Illinois at Chicago

Education

• CSIR-Central Drug Research Institute

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• MAP4K4 regulates the immune landscape of pancreatic tumor microenvironment and provides an opportunity for immunotherapy
  Cancer Letters 2026 DOI: 10.1016/j.canlet.2026.218336
  +Save
• Mixed lineage kinase 3 mediates SARS‐CoV‐2‐induced kidney injury via the Hsp70‐IL‐17A axis
  Interdisciplinary Medicine 2026 DOI: 10.1002/inmd.70154
  +Save
• Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis
  Cancer Letters 2024 DOI: 10.1016/j.canlet.2024.217200
  +Save
• MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway
  Oncogene 2024 DOI: 10.1038/s41388-024-03055-8
  +Save
• The Microbiome Modulates the Immune System to Influence Cancer Therapy
  Cancers 2024 DOI: 10.3390/cancers16040779
  +Save
• Microbiome Modulates Immune System to Influence Cancer Therapy
  Preprints.org 2024 DOI: 10.20944/PREPRINTS202401.1967.V1
  +Save
• Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases
  Cancers 2023 DOI: 10.3390/cancers15082272
  +Save
• TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer
  Oncogene 2023 DOI: 10.1038/s41388-023-02633-6
  +Save
• Advancements in Cancer Immunotherapies
  Vaccines 2022 DOI: 10.3390/vaccines11010059
  +Save
• Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver Lipid Infiltration
  Future Pharmacology 2022 DOI: 10.3390/futurepharmacol2040031
  +Save